The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia. It aims to answer: * Does sodium supplementation lower the length of hospital stay in children with pneumonia? * Does potassium supplementation lower the length of hospital stay in children with pneumonia? Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay. Participants will: • Take one sachet of oral rehydration solution (ORS) every day for 3 days.
Age range
1 Month – 5 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The difference in hospital length of stay between hospitalized children with pneumonia who received oral rehydration solution and those who did not receive it
Timeframe: Children will be followed until discharge from the hospital, an average of one week.